Etiology And Practical Prevention Of Common Complications in Breast Biopsy Needle Procedures

https://www.mayoclinic.org/tests-procedures/breast-biopsy/about/pac-20384812

Although a minimally invasive office procedure, breast biopsy is an invasive act carrying risks of hemorrhage, hematoma, infection, tissue injury, and sampling failure. These complications stem from instrument selection, operator technique, and patient factors. Mastery of their etiology and implementation of preventative measures are critical competencies for clinicians and central to training programs.

1. Intraoperative Bleeding & Post-operative Hematoma (Most Common):

Rich vascularity surrounds breast lesions, particularly malignancies. Injury to subcutaneous or deep vessels, or aggressive use of large-bore needles, precipitates bleeding and hematoma formation.

Prevention:

• Pre-procedural imaging to map vasculature and plan avascular paths.
• Rational gauge selection; avoid unnecessarily large needles.
• Smooth, steady insertion; avoid jerky motions or multiple redirections.
• Critical Step:​ Apply firm manual compression to the puncture site for 5–10 minutes immediately post-sampling. Maintain a compression dressing for 24 hours. Advise patients to avoid strenuous activity. Manage anticoagulants pre-procedure per guidelines.

2. Local Infection:

Typically results from breaches in sterile technique or poor wound care. Bacteria can infiltrate the micro-puncture, leading to cellulitis or abscess.

Prevention:

• Strict asepsis: Sterile needle handling, double skin prep with iodophor, proper draping.
• Post-op instructions: Keep the site dry for 3 days; no submersion.
• Surveillance: Instruct patients to report redness, heat, or purulent discharge for prompt antibiotic intervention.

3. Injury to Glandular Tissue or Nerves:

Often due to inexperience-erroneous angulation or depth miscalculation leading to damage to parenchyma, lymphatics, or superficial nerves, causing numbness or pain.

Prevention:

• Mandatory Imaging Guidance:​ Never perform blindly. Ensure the needle targets the lesion directly, avoiding traversal of healthy tissue.
• Controlled Advancement: Slow, steady insertion; never force the needle.
• Depth Control: Adjust depth based on lesion location-superficial lesions require shallow passes; deep lesions require precise endpoint calculation.

4. Sampling Failure & False Negatives:

The gravest diagnostic error, usually stemming from incorrect gauge selection or targeting error (e.g., sampling necrosis or missing the active tumor margin).

Prevention:

• Precision Selection:​ Use 14G+ for masses; utilize image guidance for micro-lesions.
• Adequate Sampling:​ Perform multiple passes (typically 3–6 cores) from different areas of the lesion to ensure representative sampling of viable tissue.
• Standardized instrument selection, refined technique, and rigorous protective protocols can reduce complication rates to negligible levels, fortifying the safety and diagnostic reliability of minimally invasive breast care.